Literature DB >> 17449412

Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?

Edward K Rhee1, Charles E Canter, Susan Basile, Steven A Webber, David C Naftel.   

Abstract

OBJECTIVES: The goal of this study is to determine the incidence of sudden cardiac death in children with cardiomyopathy prior to pediatric heart transplantation.
BACKGROUND: Recent primary prevention trials of implantable cardiac defibrillator (ICD) therapy in adults with ischemic and non-ischemic cardiomyopathy have shown a survival benefit. The incidence of sudden death, and thus the likelihood of improved survival with ICD therapy, in children with cardiomyopathy is currently unknown.
METHODS: The Pediatric Heart Transplant Study (PHTS) database was retrospectively queried for patients < or =18 years of age who died from any cause after listing for but prior to heart transplantation. Patients having arrhythmic or sudden death were included for study. Clinical and demographic variables were examined to identify higher-risk sub-groups.
RESULTS: Of the 2,392 patients in the PHTS database, 420 (17.6%) died prior to heart transplantation. Only 32 deaths (1.3% of total listed, 7.6% of total deaths) were sudden or arrhythmic in nature. Patients with ischemic cardiomyopathy had an increased risk of sudden death (relative risk = 6.92). Presence of congenital heart disease and United Network for Organ Sharing (UNOS) status at listing were not associated with an increased risk of sudden death.
CONCLUSIONS: The overall incidence of sudden death in children awaiting heart transplantation is low; therefore, uniform implantation of ICDs for the primary prevention of sudden death is unlikely to improve survival in this population. Children with ischemic cardiomyopathy appear to have a higher risk of sudden death and may benefit from ICD therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17449412     DOI: 10.1016/j.healun.2007.02.005

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

1.  Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Authors:  Elfriede Pahl; Lynn A Sleeper; Charles E Canter; Daphne T Hsu; Minmin Lu; Steven A Webber; Steven D Colan; Paul F Kantor; Melanie D Everitt; Jeffrey A Towbin; John L Jefferies; Beth D Kaufman; James D Wilkinson; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

Review 2.  A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease.

Authors:  Michael J Silka; Yaniv Bar-Cohen
Journal:  Pediatr Cardiol       Date:  2012-02-07       Impact factor: 1.655

3.  The relationship between electrocardiographic data and mortality in children diagnosed with dilated cardiomyopathy.

Authors:  Mehmet Türe; Hasan Balık; Alper Akın; Meki Bilici; Ahmet Nergiz
Journal:  Eur J Pediatr       Date:  2020-01-14       Impact factor: 3.183

4.  Acute isoproterenol leads to age-dependent arrhythmogenesis in guinea pigs.

Authors:  Kathleen C Woulfe; Cortney E Wilson; Shane Nau; Sarah Chau; Elisabeth K Phillips; Shulun Zang; Christine Tompkins; Carmen C Sucharov; Shelley D Miyamoto; Brian L Stauffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

5.  Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy.

Authors:  Brian Feingold; Gaurav Arora; Steven A Webber; Kenneth J Smith
Journal:  J Card Fail       Date:  2010-06-08       Impact factor: 5.712

6.  Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.

Authors:  Shelley D Miyamoto; Brian L Stauffer; Stephanie Nakano; Rebecca Sobus; Karin Nunley; Penny Nelson; Carmen C Sucharov
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

7.  Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.

Authors:  Sotiria C Apostolopoulou; George A Vagenakis; Alexandros Tsoutsinos; Felicia Kakava; Spyridon Rammos
Journal:  Pediatr Cardiol       Date:  2018-05-18       Impact factor: 1.655

8.  Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.

Authors:  Michelle Curley; Jill Liebers; Roy Maynard
Journal:  J Infus Nurs       Date:  2017 Mar/Apr

Review 9.  Current State of Pediatric Heart Failure.

Authors:  Bibhuti B Das
Journal:  Children (Basel)       Date:  2018-06-28

10.  2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.

Authors:  Maully J Shah; Michael J Silka; Jennifer N Avari Silva; Seshadri Balaji; Cheyenne M Beach; Monica N Benjamin; Charles I Berul; Bryan Cannon; Frank Cecchin; Mitchell I Cohen; Aarti S Dalal; Brynn E Dechert; Anne Foster; Roman Gebauer; M Cecilia Gonzalez Corcia; Prince J Kannankeril; Peter P Karpawich; Jeffery J Kim; Mani Ram Krishna; Peter Kubuš; Martin J LaPage; Douglas Y Mah; Lindsey Malloy-Walton; Aya Miyazaki; Kara S Motonaga; Mary C Niu; Melissa Olen; Thomas Paul; Eric Rosenthal; Elizabeth V Saarel; Massimo Stefano Silvetti; Elizabeth A Stephenson; Reina B Tan; John Triedman; Nicholas H Von Bergen; Philip L Wackel
Journal:  Indian Pacing Electrophysiol J       Date:  2021-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.